Cyteir Therapeutics, Inc. Common Stock

Go to Cyteir Therapeutics, Inc. Common Stock Website

$3.02

(%)
Live
Previous Close

$3.02

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded up 0.93% to 34,439.75 while the NASDAQ rose 1.54% to 13,800.92. The S&P 500, also rose, gaining, 1.32% to 4,454.48. Check This Out: Top 5 Tech And Telecom Stocks That Are Ticking Portfolio Bombs   Leading and Lagging Sectors Information technology shares jumped by 1.7% on Friday. In trading on Friday, real estate shares fell by 0.3%.   Top Headline The total number of active U.S. oil rigs fell by 1 to 545 rigs this week, Baker Hughes Inc reported.   Equities Trading UP Renalytix Plc (NASDAQ: RNLX) shares shot up 44% to $2.92 after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test. Shares of Baudax Bio, Inc. (NASDAQ: BXRX) got a boost, shooting 123% to $1.16 after the company agreed to acquire TeraImmune in a stock-for-stock transaction. Cyteir Therapeutics, Inc. (NASDAQ: CYT) shares were also up, gaining 38% to $2.65 after the company announced that it is discontinuing all development of CYT-0851, dissolving the company and liquidating its assets.   Equities Trading DOWN Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares dropped 26% to $1.2150 after the company provided an update concerning its marketing application for lanthanum dioxycarbonate for hyperphosphatemia in chronic kidney ...

Related tickers: CYT, ROOT, BXRX, RNLX, UNCY, CNVS.

Read Full Article

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms. CymaBay Therapeutics, Inc. (NASDAQ: CBAY) surged 40% to $10.97. Cyteir Therapeutics, Inc. (NASDAQ: CYT) shares gained 38% to $2.6487. Cyteir Therapeutics reported discontinuation of CYT-0851 development program and planned liquidation and dissolution. TOP Financial Group Limited (NASDAQ: TOP) shares gained 32.2% to $10.31 after the company reported FY23 financial results. Renalytix Plc (NASDAQ: RNLX) shares jumped 31% to $2.66 after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test. Baudax Bio, Inc. (NASDAQ: BXRX) gained 24% to $0.6450 after the company agreed to acquire TeraImmune in a stock-for-stock transaction. Friedman Industries, Incorporated (NYSE: FRD) rose 19.6% to $11.90 after posting a profit for the fourth quarter. CytomX Therapeutics, Inc. (NASDAQ: CTMX) gained 17.7% to $1.65 after the company announced a $30 million private placement from BVF Partners L.P. Rackspace Technology, Inc. (NASDAQ: RXT) gained 15.8% to $2.27. Rackspace Technology partnered with Google Cloud to offer cutting-edge generative AI services and solutions using the FAIR practice. Applied Optoelectronics, Inc. (NASDAQ: AAOI) gained 15.5% to $6.27. MicroVision, Inc. (NASDAQ: MVIS) climbed 12.8% to $4.40. XPeng Inc. (NYSE: XPEV) gained 12.4% to $13.29 after CLSA upgraded the stock from Buy to Outperform and raised the price target from $10 to $13.1. The company, on Thursday. launched G6 Ultra Smart Coupe ...

Related tickers: XPEV, EVLO, KRBP, EIGR, FHTX, FRD, TOP, EOSE, NVX, ATXG, UNCY, FLWS, ROOT, HILS, MVIS, APYX, IMBIL, PIII, BTTR, ALVO, CCL, DUO, GSUN, CYT, BXRX, BACK, TSP, PALT, ACCD, CNVS, AAOI, RNLX, CBAY, OTRK, AHI, RXT, AUPH, SRGA, APPS, KTRA, CTMX.

Read Full Article
Trending Tickers

Please sign in to view